Scope These ESCMID guidelines address the targeted antibiotic treatment of third-
generation cephalosporin-resistant Enterobacterales (3GCephRE) and carbapenem …

Background Antimicrobial resistance is an increasingly serious threat to public health, and
the increased occurrence of multidrug-resistant (MDR) bacteria is a concern in both high …

Infections caused by carbapenemase-producing, multidrug-resistant (MDR), or extensively
drug-resistant (XDR) Gram-negative bacteria constitute a major therapeutic challenge …

Clinicians may use ceftazidime/avibactam in combination with other active agents to treat
infections due to carbapenem-resistant organisms, although no conclusive data support this …

Background Rates of colonization and infection with carbapenem-resistant Gram-negative
pathogens are on the rise, particularly in southeastern European countries, and this is …

Abstract The Working Party makes more than 100 tabulated recommendations in
antimicrobial prescribing for the treatment of infections caused by multidrug-resistant (MDR) …

Management of patients with infections caused by multidrug-resistant organisms is
challenging and requires a multidisciplinary approach to achieve successful clinical …

Infections due to carbapenem-resistant Gram-negative bacteria are burdened by high
mortality and represent an urgent threat to address. Clinicians are currently at a dawn of a …

Objectives To explore contemporary antibiotic management of infections caused by
carbapenem-resistant Gram-negative bacteria in hospitals. Methods Cross-sectional …

The increasing prevalence of infections due to multidrug-resistant (MDR) gram-negative
bacteria constitutes a serious threat to global public health due to the limited treatment …